Clinical Trial Update: Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of brexpiprazole as adjunctive therapy in elderly patients with major depressive disorder has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2016-02-04